Non-alcoholic fatty liver disease in adults 2021: A clinical practice guideline of the Italian Association for the Study of the Liver (AISF), the Italian Society of Diabetology (SID) and the Italian Society of Obesity (SIO)
Published 2021 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Non-alcoholic fatty liver disease in adults 2021: A clinical practice guideline of the Italian Association for the Study of the Liver (AISF), the Italian Society of Diabetology (SID) and the Italian Society of Obesity (SIO)
Authors
Keywords
-
Journal
NUTRITION METABOLISM AND CARDIOVASCULAR DISEASES
Volume 32, Issue 1, Pages 1-16
Publisher
Elsevier BV
Online
2021-12-16
DOI
10.1016/j.numecd.2021.04.028
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Management of non-alcoholic fatty liver disease
- (2021) Maria Letizia Petroni et al. BMJ-British Medical Journal
- Assessment of hepatic steatosis by controlled attenuation parameter using the M and XL probes: an individual patient data meta-analysis
- (2021) David Petroff et al. Lancet Gastroenterology & Hepatology
- Lifestyle changes for the treatment of nonalcoholic fatty liver disease – A 2015-19 update
- (2020) Maria Letizia Petroni et al. CURRENT PHARMACEUTICAL DESIGN
- Liver‐related long‐term outcomes of thiazolidinedione use in persons with type 2 diabetes
- (2020) Fu‐Shun Yen et al. LIVER INTERNATIONAL
- Combined and sequential non-invasive approach to diagnosing non-alcoholic steatohepatitis in patients with non-alcoholic fatty liver disease and persistently normal alanine aminotransferase levels
- (2020) Kenneth I Zheng et al. BMJ Open Diabetes Research & Care
- Light-to-Moderate Alcohol Consumption Is Associated With Increased Risk of Type 2 Diabetes in Individuals With Nonalcoholic Fatty Liver Disease
- (2020) Lei Xu et al. AMERICAN JOURNAL OF GASTROENTEROLOGY
- A new definition for metabolic dysfunction-associated fatty liver disease: An international expert consensus statement
- (2020) Mohammed Eslam et al. JOURNAL OF HEPATOLOGY
- Healthcare resource utilization and costs of nonalcoholic steatohepatitis patients with advanced liver disease in Italy
- (2020) Salvatore Petta et al. NUTRITION METABOLISM AND CARDIOVASCULAR DISEASES
- Monitoring Occurrence of Liver-Related Events and Survival by Transient Elastography in Patients With Nonalcoholic Fatty Liver Disease and Compensated Advanced Chronic Liver disease
- (2020) Salvatore Petta et al. Clinical Gastroenterology and Hepatology
- Bariatric Surgery Provides Long-term Resolution of Nonalcoholic Steatohepatitis and Regression of Fibrosis
- (2020) Guillaume Lassailly et al. GASTROENTEROLOGY
- Global epidemiology of lean non‐alcoholic fatty liver disease: A systematic review and meta‐analysis
- (2020) Feng‐Bin Lu et al. JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY
- Repeated FIB-4 measurements can help identify individuals at risk of severe liver disease
- (2020) Hannes Hagström et al. JOURNAL OF HEPATOLOGY
- A Placebo-Controlled Trial of Subcutaneous Semaglutide in Nonalcoholic Steatohepatitis
- (2020) Philip N. Newsome et al. NEW ENGLAND JOURNAL OF MEDICINE
- Diagnostic Accuracy of Non-Invasive Fibrosis Models to Detect Change in Fibrosis Stage
- (2019) M. Shadab Siddiqui et al. Clinical Gastroenterology and Hepatology
- Genetics of Nonalcoholic Fatty Liver Disease: a 2018 Update.
- (2019) Luca VC Valenti et al. CURRENT PHARMACEUTICAL DESIGN
- Non-Invasive Assessment of Liver Disease in Patients with NAFLD
- (2019) Laurent Castera et al. GASTROENTEROLOGY
- Unified interpretation of liver stiffness measurement by M and XL probes in non-alcoholic fatty liver disease
- (2019) Vincent Wai-Sun Wong et al. GUT
- NASH in Lean Individuals
- (2019) Ramy Younes et al. SEMINARS IN LIVER DISEASE
- Post hoc analyses of surrogate markers of non-alcoholic fatty liver disease (NAFLD) and liver fibrosis in patients with type 2 diabetes in a digitally supported continuous care intervention: an open-label, non-randomised controlled study
- (2019) Eduardo Vilar-Gomez et al. BMJ Open
- Non-invasive fibrosis scoring systems can predict future metabolic complications and overall mortality in non-alcoholic fatty liver disease (NAFLD)
- (2019) Kristina Önnerhag et al. SCANDINAVIAN JOURNAL OF GASTROENTEROLOGY
- Accuracy of FibroScan Controlled Attenuation Parameter and Liver Stiffness Measurement in Assessing Steatosis and Fibrosis in Patients With Nonalcoholic Fatty Liver Disease
- (2019) Peter J. Eddowes et al. GASTROENTEROLOGY
- Diagnostic value of MRI-PDFF for hepatic steatosis in patients with non-alcoholic fatty liver disease: a meta-analysis
- (2019) Jiulian Gu et al. EUROPEAN RADIOLOGY
- Diagnostic accuracy of controlled attenuation parameter (CAP) as a non-invasive test for steatosis in suspected non-alcoholic fatty liver disease: a systematic review and meta-analysis
- (2019) Ke Pu et al. BMC GASTROENTEROLOGY
- The Natural History of Advanced Fibrosis Due to Nonalcoholic Steatohepatitis: Data From the Simtuzumab Trials
- (2019) Arun J. Sanyal et al. HEPATOLOGY
- Outcomes of Liver Transplantation for Non-alcoholic Steatohepatitis: a European Liver Transplant Registry Study
- (2019) Debashis Haldar et al. JOURNAL OF HEPATOLOGY
- Prospective evaluation of a primary care referral pathway for patients with non-alcoholic fatty liver disease
- (2019) Ankur Srivastava et al. JOURNAL OF HEPATOLOGY
- Models estimating risk of hepatocellular carcinoma in patients with alcohol or NAFLD-related cirrhosis for risk stratification
- (2019) George N. Ioannou et al. JOURNAL OF HEPATOLOGY
- The Beneficial effects of Mediterranean diet over low-fat diet may be mediated by decreasing hepatic fat content
- (2019) Yftach Gepner et al. JOURNAL OF HEPATOLOGY
- Effect of semaglutide on liver enzymes and markers of inflammation in subjects with type 2 diabetes and/or obesity
- (2019) Philip Newsome et al. ALIMENTARY PHARMACOLOGY & THERAPEUTICS
- Impact of Obesity and Alanine Aminotransferase Levels on the Diagnostic Accuracy for Advanced Liver Fibrosis of Noninvasive Tools in Patients With Nonalcoholic Fatty Liver Disease
- (2019) Salvatore Petta et al. AMERICAN JOURNAL OF GASTROENTEROLOGY
- Cost-comparison analysis of FIB-4, ELF and fibroscan in community pathways for non-alcoholic fatty liver disease
- (2019) Ankur Srivastava et al. BMC GASTROENTEROLOGY
- Role of Vitamin E for Nonalcoholic Steatohepatitis in Patients With Type 2 Diabetes: A Randomized Controlled Trial
- (2019) Fernando Bril et al. DIABETES CARE
- Low levels of alcohol consumption, obesity and development of fatty liver with and without evidence of advanced fibrosis
- (2019) Yoosoo Chang et al. HEPATOLOGY
- Noninvasive tests accurately identify advanced fibrosis due to NASH : Baseline data from the STELLAR trials
- (2019) Quentin M. Anstee et al. HEPATOLOGY
- Risks of light and moderate alcohol use in fatty liver disease – follow‐up of population cohorts
- (2019) Fredrik Åberg et al. HEPATOLOGY
- The Global Epidemiology of NAFLD and NASH in Patients with type 2 diabetes: A Systematic Review and Meta-analysis
- (2019) Zobair M. Younossi et al. JOURNAL OF HEPATOLOGY
- Report on the AASLD/EASL joint workshop on clinical trial endpoints in NAFLD
- (2019) Mary E. Rinella et al. JOURNAL OF HEPATOLOGY
- Class effects of SGLT2 inhibitors on cardiorenal outcomes
- (2019) Aaron Y. Kluger et al. Cardiovascular Diabetology
- Association Between PNPLA3 rs738409 C>G Variant and Liver-Related Outcomes in Patients with Non-alcoholic Fatty Liver Disease
- (2019) Stefania Grimaudo et al. Clinical Gastroenterology and Hepatology
- The Risk of Incident Extrahepatic Cancers is higher in Nonalcoholic Fatty Liver Disease than Obesity - a Longitudinal Cohort Study
- (2019) Alina M. Allen et al. JOURNAL OF HEPATOLOGY
- RoB 2: a revised tool for assessing risk of bias in randomised trials
- (2019) Jonathan A C Sterne et al. BMJ-British Medical Journal
- Direct comparison of the specialised blood fibrosis tests FibroMeterV2G and Enhanced Liver Fibrosis score in patients with non-alcoholic fatty liver disease from tertiary care centres
- (2019) Maeva Guillaume et al. ALIMENTARY PHARMACOLOGY & THERAPEUTICS
- Higher liver stiffness scores are associated with early kidney dysfunction in patients with histologically proven non-cirrhotic NAFLD
- (2019) Dan-Qin Sun et al. DIABETES & METABOLISM
- Performance of Plasma Biomarkers and Diagnostic Panels for Nonalcoholic Steatohepatitis and Advanced Fibrosis in Patients With Type 2 Diabetes
- (2019) Fernando Bril et al. DIABETES CARE
- Effect of Metabolic Traits on the Risk of Cirrhosis and Hepatocellular Cancer in Non‐alcoholic Fatty Liver Disease
- (2019) Fasiha Kanwal et al. HEPATOLOGY
- Cardiovascular, mortality, and kidney outcomes with GLP-1 receptor agonists in patients with type 2 diabetes: a systematic review and meta-analysis of cardiovascular outcome trials
- (2019) Søren L Kristensen et al. Lancet Diabetes & Endocrinology
- Effect of PNPLA3 polymorphism on diagnostic performance of various noninvasive markers for diagnosing and staging nonalcoholic fatty liver disease
- (2019) Wen‐Yue Liu et al. JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY
- Obeticholic acid for the treatment of non-alcoholic steatohepatitis: interim analysis from a multicentre, randomised, placebo-controlled phase 3 trial
- (2019) Zobair M Younossi et al. LANCET
- Liver stiffness measurement predicts long‐term survival and complications in non‐alcoholic fatty liver disease
- (2019) Sarah Shili‐Masmoudi et al. LIVER INTERNATIONAL
- Impact of controlled attenuation parameter on detecting fibrosis using liver stiffness measurement
- (2018) T. Karlas et al. ALIMENTARY PHARMACOLOGY & THERAPEUTICS
- Magnetic Resonance vs Transient Elastography Analysis of Patients With Non-alcoholic Fatty Liver Disease: a Systematic Review and Pooled Analysis of Individual Participants
- (2018) Cynthia Hsu et al. Clinical Gastroenterology and Hepatology
- Noninvasive Tests Do Not Accurately Differentiate Nonalcoholic Steatohepatitis From Simple Steatosis: A Systematic Review and Meta-analysis
- (2018) Pauline Verhaegh et al. Clinical Gastroenterology and Hepatology
- Among Patients With Nonalcoholic Fatty Liver Disease, Modest Alcohol Use Is Associated With Less Improvement in Histologic Steatosis and Steatohepatitis
- (2018) Veeral Ajmera et al. Clinical Gastroenterology and Hepatology
- Effect of Empagliflozin on Liver Fat in Patients With Type 2 Diabetes and Nonalcoholic Fatty Liver Disease: A Randomized Controlled Trial (E-LIFT Trial)
- (2018) Mohammad Shafi Kuchay et al. DIABETES CARE
- Trend over time in hepatic fibrosis score in a cohort of type 2 diabetes patients
- (2018) Carlo Bruno Giorda et al. DIABETES RESEARCH AND CLINICAL PRACTICE
- Effects of dapagliflozin and n-3 carboxylic acids on non-alcoholic fatty liver disease in people with type 2 diabetes: a double-blind randomised placebo-controlled study
- (2018) Jan W. Eriksson et al. DIABETOLOGIA
- Fibrosis Severity as a Determinant of Cause-Specific Mortality in Patients With Advanced Nonalcoholic Fatty Liver Disease
- (2018) Eduardo Vilar-Gomez et al. GASTROENTEROLOGY
- Magnetic Resonance Imaging Proton Density Fat Fraction Associates With Progression of Fibrosis in Patients With Nonalcoholic Fatty Liver Disease
- (2018) Veeral Ajmera et al. GASTROENTEROLOGY
- Optimal threshold of controlled attenuation parameter with MRI-PDFF as the gold standard for the detection of hepatic steatosis
- (2018) Cyrielle Caussy et al. HEPATOLOGY
- Non-heavy drinking and worsening of non-invasive fibrosis markers in nonalcoholic fatty liver disease: A cohort study
- (2018) Yoosoo Chang et al. HEPATOLOGY
- Can the same controlled attenuation parameter cut-offs be used for M and XL probes for diagnosing hepatic steatosis?
- (2018) Wah-Kheong Chan et al. JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY
- Non-invasive assessment of non-alcoholic fatty liver disease: Clinical prediction rules and blood-based biomarkers
- (2018) Eduardo Vilar-Gomez et al. JOURNAL OF HEPATOLOGY
- Role of imaging-based biomarkers in NAFLD: Recent advances in clinical application and future research directions
- (2018) Rohit Loomba JOURNAL OF HEPATOLOGY
- Should we undertake surveillance for HCC in patients with NAFLD?
- (2018) Ramy Younes et al. JOURNAL OF HEPATOLOGY
- Genetics and epigenetics of NAFLD and NASH: Clinical impact
- (2018) Mohammed Eslam et al. JOURNAL OF HEPATOLOGY
- Hypertension, diabetes, atherosclerosis and NASH: Cause or consequence?
- (2018) Amedeo Lonardo et al. JOURNAL OF HEPATOLOGY
- Prevalence and severity of nonalcoholic fatty liver disease by transient elastography: Genetic and metabolic risk factors in a general population
- (2018) Salvatore Petta et al. LIVER INTERNATIONAL
- Diabetes impacts prediction of cirrhosis and prognosis by non-invasive fibrosis models in non-alcoholic fatty liver disease
- (2018) Luis C. Bertot et al. LIVER INTERNATIONAL
- Coronary artery disease in decompensated patients undergoing liver transplantation evaluation
- (2018) Samarth S. Patel et al. LIVER TRANSPLANTATION
- Nonalcoholic fatty liver disease increases risk of incident chronic kidney disease: A systematic review and meta-analysis
- (2018) Alessandro Mantovani et al. METABOLISM-CLINICAL AND EXPERIMENTAL
- Expert consensus document: Clinical and molecular diagnosis, screening and management of Beckwith–Wiedemann syndrome: an international consensus statement
- (2018) Frédéric Brioude et al. Nature Reviews Endocrinology
- Noninvasive biomarkers in NAFLD and NASH — current progress and future promise
- (2018) Vincent Wai-Sun Wong et al. Nature Reviews Gastroenterology & Hepatology
- A Protein-Truncating HSD17B13 Variant and Protection from Chronic Liver Disease
- (2018) Noura S. Abul-Husn et al. NEW ENGLAND JOURNAL OF MEDICINE
- Systematic review with meta-analysis: risk of hepatocellular carcinoma in non-alcoholic steatohepatitis without cirrhosis compared to other liver diseases
- (2018) Jonathan G. Stine et al. ALIMENTARY PHARMACOLOGY & THERAPEUTICS
- GPs’ experiences and perceptions of early detection of liver disease: a qualitative study in primary care
- (2018) Holly C Standing et al. BRITISH JOURNAL OF GENERAL PRACTICE
- Evaluation of the effects of dapagliflozin, an SGLT2 inhibitor, on hepatic steatosis and fibrosis by transient elastography in patients with type 2 diabetes and non-alcoholic fatty liver disease
- (2018) Masanori Shimizu et al. DIABETES OBESITY & METABOLISM
- Empagliflozin is associated with improvements in liver enzymes potentially consistent with reductions in liver fat: results from randomised trials including the EMPA-REG OUTCOME® trial
- (2018) Naveed Sattar et al. DIABETOLOGIA
- Effect of alcohol consumption on survival in non-alcoholic fatty liver disease: a national prospective cohort study
- (2018) Kaveh Hajifathalian et al. HEPATOLOGY
- Burden of Illness and Economic Model for Patients with Non-Alcoholic Steatohepatitis (NASH) in the United States
- (2018) Zobair M. Younossi et al. HEPATOLOGY
- Beneficial effects of lifestyle intervention in non-obese patients with non-alcoholic fatty liver disease
- (2018) Vincent Wai-Sun Wong et al. JOURNAL OF HEPATOLOGY
- International Liver Transplantation Consensus Statement on end-stage liver disease due to nonalcoholic steatohepatitis and liver transplantation
- (2018) Emmanuel Tsochatzis et al. TRANSPLANTATION
- Long-term prognostic value of the FibroTest in patients with non-alcoholic fatty liver disease, compared to chronic hepatitis C, B, and alcoholic liver disease
- (2018) Mona Munteanu et al. ALIMENTARY PHARMACOLOGY & THERAPEUTICS
- Accuracy of Non-invasive Scoring Systems in Assessing Risk of Death and Liver-related Endpoints in Patients With Non-alcoholic Fatty Liver Disease
- (2018) Hannes Hagström et al. Clinical Gastroenterology and Hepatology
- 9. Pharmacologic Approaches to Glycemic Treatment: Standards of Medical Care in Diabetes—2019
- (2018) DIABETES CARE
- Effect of canagliflozin treatment on hepatic triglyceride content and glucose metabolism in patients with type 2 diabetes
- (2018) Kenneth Cusi et al. DIABETES OBESITY & METABOLISM
- Epidemiology and Management of Hepatocellular Carcinoma
- (2018) Laura Kulik et al. GASTROENTEROLOGY
- Vitamin E Improves Transplant-free Survival and Hepatic Decompensation among Patients with NASH and Advanced Fibrosis
- (2018) Eduardo Vilar-Gomez et al. HEPATOLOGY
- Liraglutide, sitagliptin and insulin glargine added to metformin: the effect on body weight and intrahepatic lipid in patients with type 2 diabetes mellitus and NAFLD
- (2018) Jinhua Yan et al. HEPATOLOGY
- An internet-based approach for lifestyle changes in patients with NAFLD: Two-year effects on weight loss and surrogate markers
- (2018) Arianna Mazzotti et al. JOURNAL OF HEPATOLOGY
- Non-alcoholic fatty liver disease – A global public health perspective
- (2018) Zobair M. Younossi JOURNAL OF HEPATOLOGY
- Recommendations for Management and Treatment of Nonalcoholic Steatohepatitis
- (2018) Vlad Ratziu et al. TRANSPLANTATION
- Management of Recurrent and De Novo NAFLD/NASH After Liver Transplantation
- (2018) Giacomo Germani et al. TRANSPLANTATION
- Short article
- (2017) Xiao-Long Deng et al. EUROPEAN JOURNAL OF GASTROENTEROLOGY & HEPATOLOGY
- Alcohol Use and Cardiovascular Disease Risk in Patients With Nonalcoholic Fatty Liver Disease
- (2017) Lisa B. VanWagner et al. GASTROENTEROLOGY
- Pioglitazone for advanced fibrosis in nonalcoholic steatohepatitis: New evidence, new challenges
- (2017) Giovanni Musso et al. HEPATOLOGY
- Comparison of laboratory tests, ultrasound, or magnetic resonance elastography to detect fibrosis in patients with nonalcoholic fatty liver disease: A meta-analysis
- (2017) Guangqin Xiao et al. HEPATOLOGY
- Bariatric surgery for nonalcoholic steatohepatitis: A clinical and cost-effectiveness analysis
- (2017) Matthew J. Klebanoff et al. HEPATOLOGY
- The diagnosis and management of nonalcoholic fatty liver disease: Practice guidance from the American Association for the Study of Liver Diseases
- (2017) Naga Chalasani et al. HEPATOLOGY
- A stepwise algorithm using an at-a-glance first-line test for the non-invasive diagnosis of advanced liver fibrosis and cirrhosis
- (2017) Jérôme Boursier et al. JOURNAL OF HEPATOLOGY
- Individual patient data meta-analysis of controlled attenuation parameter (CAP) technology for assessing steatosis
- (2017) Thomas Karlas et al. JOURNAL OF HEPATOLOGY
- Aerobic vs. resistance exercise in non-alcoholic fatty liver disease: A systematic review
- (2017) Ryuki Hashida et al. JOURNAL OF HEPATOLOGY
- Treatment of NAFLD with diet, physical activity and exercise
- (2017) Manuel Romero-Gómez et al. JOURNAL OF HEPATOLOGY
- Causal relationship of hepatic fat with liver damage and insulin resistance in nonalcoholic fatty liver
- (2017) P. Dongiovanni et al. JOURNAL OF INTERNAL MEDICINE
- Steatosis severity affects the diagnostic performances of noninvasive fibrosis tests in nonalcoholic fatty liver disease
- (2017) Sae Kyung Joo et al. LIVER INTERNATIONAL
- Cardiac function, A key component in evaluation for liver transplant
- (2017) Raquel Yotti et al. LIVER TRANSPLANTATION
- The Role of Bariatric Surgery in Abdominal Organ Transplantation—the Next Big Challenge?
- (2017) Tomasz Dziodzio et al. OBESITY SURGERY
- The PNPLA3 I148M variant is associated with transaminase elevations in type 2 diabetes patients treated with basal insulin peglispro
- (2017) S Pillai et al. PHARMACOGENOMICS JOURNAL
- Incidence of and Risk Assessment for Adverse Cardiovascular Outcomes After Liver Transplantation
- (2017) Monica A. Konerman et al. TRANSPLANTATION
- Pioglitazone and cardiovascular outcomes in patients with insulin resistance, pre-diabetes and type 2 diabetes: a systematic review and meta-analysis
- (2017) Hung-Wei Liao et al. BMJ Open
- Randomized trial comparing the effects of gliclazide, liraglutide, and metformin on diabetes with non-alcoholic fatty liver disease
- (2017) Wenhuan Feng et al. Journal of Diabetes
- Improvement in liver histology due to lifestyle modification is independently associated with improved kidney function in patients with non-alcoholic steatohepatitis
- (2016) E. Vilar-Gomez et al. ALIMENTARY PHARMACOLOGY & THERAPEUTICS
- Age as a Confounding Factor for the Accurate Non-Invasive Diagnosis of Advanced NAFLD Fibrosis
- (2016) Stuart McPherson et al. AMERICAN JOURNAL OF GASTROENTEROLOGY
- Clinical and Metabolic Characterization of Lean Caucasian Subjects With Non-alcoholic Fatty Liver
- (2016) Alexandra Feldman et al. AMERICAN JOURNAL OF GASTROENTEROLOGY
- Long-Term Pioglitazone Treatment for Patients With Nonalcoholic Steatohepatitis and Prediabetes or Type 2 Diabetes Mellitus
- (2016) Kenneth Cusi et al. ANNALS OF INTERNAL MEDICINE
- Epidemiology of Nonalcoholic Fatty Liver Disease and Nonalcoholic Steatohepatitis in the United States and the Rest of the World
- (2016) Mehmet Sayiner et al. Clinics in Liver Disease
- Effect of canagliflozin on liver function tests in patients with type 2 diabetes
- (2016) L.A. Leiter et al. DIABETES & METABOLISM
- Risk of type 2 diabetes in patients with non-alcoholic fatty liver disease: Causal association or epiphenomenon?
- (2016) G. Targher et al. DIABETES & METABOLISM
- Exenatide decreases liver fat content and epicardial adipose tissue in patients with obesity and type 2 diabetes: a prospective randomized clinical trial using magnetic resonance imaging and spectroscopy
- (2016) A. Dutour et al. DIABETES OBESITY & METABOLISM
- Contribution of Alcoholic and Nonalcoholic Fatty Liver Disease to the Burden of Liver-Related Morbidity and Mortality
- (2016) Zobair Younossi et al. GASTROENTEROLOGY
- The MBOAT7-TMC4 Variant rs641738 Increases Risk of Nonalcoholic Fatty Liver Disease in Individuals of European Descent
- (2016) Rosellina Margherita Mancina et al. GASTROENTEROLOGY
- Liver stiffness in nonalcoholic fatty liver disease: A comparison of supersonic shear imaging, FibroScan, and ARFI with liver biopsy
- (2016) Christophe Cassinotto et al. HEPATOLOGY
- Diet, weight loss, and liver health in nonalcoholic fatty liver disease: Pathophysiology, evidence, and practice
- (2016) Giulio Marchesini et al. HEPATOLOGY
- Improved noninvasive prediction of liver fibrosis by liver stiffness measurement in patients with nonalcoholic fatty liver disease accounting for controlled attenuation parameter values
- (2016) Salvatore Petta et al. HEPATOLOGY
- Global epidemiology of nonalcoholic fatty liver disease-Meta-analytic assessment of prevalence, incidence, and outcomes
- (2016) Zobair M. Younossi et al. HEPATOLOGY
- Clinical patterns of hepatocellular carcinoma in nonalcoholic fatty liver disease: A multicenter prospective study
- (2016) Fabio Piscaglia et al. HEPATOLOGY
- Comparison of FIB-4 index, NAFLD fibrosis score and BARD score for prediction of advanced fibrosis in adult patients with non-alcoholic fatty liver disease: A meta-analysis study
- (2016) Wenjing Sun et al. HEPATOLOGY RESEARCH
- Nonalcoholic fatty liver disease is associated with an almost twofold increased risk of incident type 2 diabetes and metabolic syndrome. Evidence from a systematic review and meta-analysis
- (2016) Stefano Ballestri et al. JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY
- Overweight in late adolescence predicts development of severe liver disease later in life: A 39years follow-up study
- (2016) Hannes Hagström et al. JOURNAL OF HEPATOLOGY
- Type 2 diabetes and risk of hospital admission or death for chronic liver diseases
- (2016) Sarah H. Wild et al. JOURNAL OF HEPATOLOGY
- Diagnostic accuracy and prognostic significance of blood fibrosis tests and liver stiffness measurement by FibroScan in non-alcoholic fatty liver disease
- (2016) Jérôme Boursier et al. JOURNAL OF HEPATOLOGY
- EASL–EASD–EASO Clinical Practice Guidelines for the management of non-alcoholic fatty liver disease
- (2016) JOURNAL OF HEPATOLOGY
- Sitagliptin vs. placebo for non-alcoholic fatty liver disease: A randomized controlled trial
- (2016) Jeffrey Cui et al. JOURNAL OF HEPATOLOGY
- Non-alcoholic fatty liver disease and risk of incident cardiovascular disease: A meta-analysis
- (2016) Giovanni Targher et al. JOURNAL OF HEPATOLOGY
- Liraglutide safety and efficacy in patients with non-alcoholic steatohepatitis (LEAN): a multicentre, double-blind, randomised, placebo-controlled phase 2 study
- (2016) Matthew James Armstrong et al. LANCET
- Global, regional, and national life expectancy, all-cause mortality, and cause-specific mortality for 249 causes of death, 1980–2015: a systematic analysis for the Global Burden of Disease Study 2015
- (2016) Haidong Wang et al. LANCET
- Pioglitazone after Ischemic Stroke or Transient Ischemic Attack
- (2016) Walter N. Kernan et al. NEW ENGLAND JOURNAL OF MEDICINE
- The association of lean and fat mass with all-cause mortality in older adults: The Cardiovascular Health Study
- (2016) A. Spahillari et al. NUTRITION METABOLISM AND CARDIOVASCULAR DISEASES
- The spectrum effect in tests for risk prediction, screening, and diagnosis
- (2016) Juliet A Usher-Smith et al. BMJ-British Medical Journal
- ROBINS-I: a tool for assessing risk of bias in non-randomised studies of interventions
- (2016) Jonathan AC Sterne et al. BMJ-British Medical Journal
- The spectrum effect in tests for risk prediction, screening, and diagnosis
- (2016) Juliet A Usher-Smith et al. BMJ-British Medical Journal
- ROBINS-I: a tool for assessing risk of bias in non-randomised studies of interventions
- (2016) Jonathan AC Sterne et al. BMJ-British Medical Journal
- The Burden of NAFLD and Its Characteristics in a Nationwide Population with Type 2 Diabetes
- (2016) Gabriele Forlani et al. Journal of Diabetes Research
- Fibrosis Progression in Nonalcoholic Fatty Liver vs Nonalcoholic Steatohepatitis: A Systematic Review and Meta-analysis of Paired-Biopsy Studies
- (2015) Siddharth Singh et al. Clinical Gastroenterology and Hepatology
- Independent Association Between Improvement of Nonalcoholic Fatty Liver Disease and Reduced Incidence of Type 2 Diabetes
- (2015) Hajime Yamazaki et al. DIABETES CARE
- Incidence and remission of type 2 diabetes in relation to degree of obesity at baseline and 2 year weight change: the Swedish Obese Subjects (SOS) study
- (2015) Kajsa Sjöholm et al. DIABETOLOGIA
- The effect of thiazolidinediones on bone mineral density and bone turnover: systematic review and meta-analysis
- (2015) Emma O. Billington et al. DIABETOLOGIA
- Epidemiological modifiers of non-alcoholic fatty liver disease: Focus on high-risk groups
- (2015) Amedeo Lonardo et al. DIGESTIVE AND LIVER DISEASE
- Weight Loss for a Healthy Liver
- (2015) Giulio Marchesini et al. GASTROENTEROLOGY
- Weight Loss Through Lifestyle Modification Significantly Reduces Features of Nonalcoholic Steatohepatitis
- (2015) Eduardo Vilar-Gomez et al. GASTROENTEROLOGY
- Liver Fibrosis, but No Other Histologic Features, Is Associated With Long-term Outcomes of Patients With Nonalcoholic Fatty Liver Disease
- (2015) Paul Angulo et al. GASTROENTEROLOGY
- Bariatric Surgery Reduces Features of Nonalcoholic Steatohepatitis in Morbidly Obese Patients
- (2015) Guillaume Lassailly et al. GASTROENTEROLOGY
- The severity of steatosis influences liver stiffness measurement in patients with nonalcoholic fatty liver disease
- (2015) Salvatore Petta et al. HEPATOLOGY
- Association of nonalcoholic fatty liver disease (NAFLD) with hepatocellular carcinoma (HCC) in the United States from 2004 to 2009
- (2015) Zobair M. Younossi et al. HEPATOLOGY
- Fibrosis stage is the strongest predictor for disease-specific mortality in NAFLD after up to 33 years of follow-up
- (2015) Mattias Ekstedt et al. HEPATOLOGY
- Pioglitazone Use and Risk of Bladder Cancer and Other Common Cancers in Persons With Diabetes
- (2015) James D. Lewis et al. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
- Effect of Vildagliptin on Hepatic Steatosis
- (2015) Mavin Macauley et al. JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM
- Reply to: HCC and liver disease risk in homozygous PNPLA3 p.I148M carriers approach monogenic inheritance
- (2015) Quentin M. Anstee et al. JOURNAL OF HEPATOLOGY
- Relationship of sitting time and physical activity with non-alcoholic fatty liver disease
- (2015) Seungho Ryu et al. JOURNAL OF HEPATOLOGY
- Incidence of non-alcoholic fatty liver disease in Hong Kong: A population study with paired proton-magnetic resonance spectroscopy
- (2015) Vincent Wai-Sun Wong et al. JOURNAL OF HEPATOLOGY
- NAFLD: A multisystem disease
- (2015) Christopher D. Byrne et al. JOURNAL OF HEPATOLOGY
- Farnesoid X nuclear receptor ligand obeticholic acid for non-cirrhotic, non-alcoholic steatohepatitis (FLINT): a multicentre, randomised, placebo-controlled trial
- (2015) Brent A Neuschwander-Tetri et al. LANCET
- Vitamin E has a beneficial effect on nonalcoholic fatty liver disease: A meta-analysis of randomized controlled trials
- (2015) Ken Sato et al. NUTRITION
- Body mass index in school-aged children and the risk of routinely diagnosed non-alcoholic fatty liver disease in adulthood: a prospective study based on the Copenhagen School Health Records Register
- (2015) E. Zimmermann et al. BMJ Open
- The benefits of exercise for patients with non-alcoholic fatty liver disease
- (2015) Shelley E Keating et al. Expert Review of Gastroenterology & Hepatology
- Prognostic Value of Non-Invasive Fibrosis and Steatosis Tools, Hepatic Venous Pressure Gradient (HVPG) and Histology in Nonalcoholic Steatohepatitis
- (2015) Giada Sebastiani et al. PLoS One
- Performance and limitations of steatosis biomarkers in patients with nonalcoholic fatty liver disease
- (2014) L. Fedchuk et al. ALIMENTARY PHARMACOLOGY & THERAPEUTICS
- The impact of type 2 diabetes and obesity on the long-term outcomes of more than 85 000 liver transplant recipients in the US
- (2014) Z. M. Younossi et al. ALIMENTARY PHARMACOLOGY & THERAPEUTICS
- Mortality From Chronic Liver Diseases in Diabetes
- (2014) Giacomo Zoppini et al. AMERICAN JOURNAL OF GASTROENTEROLOGY
- Prevalence and Prediction of Coronary Artery Disease in Patients With Liver Cirrhosis
- (2014) Jihyun An et al. CIRCULATION
- 2014 ACC/AHA Guideline on Perioperative Cardiovascular Evaluation and Management of Patients Undergoing Noncardiac Surgery: Executive Summary
- (2014) Lee A. Fleisher et al. CIRCULATION
- Benefits of exenatide on obesity and non-alcoholic fatty liver disease with elevated liver enzymes in patients with type 2 diabetes
- (2014) Ning Shao et al. DIABETES-METABOLISM RESEARCH AND REVIEWS
- Utility and appropriateness of the fatty liver inhibition of progression (FLIP) algorithm and steatosis, activity, and fibrosis (SAF) score in the evaluation of biopsies of nonalcoholic fatty liver disease
- (2014) Pierre Bedossa et al. HEPATOLOGY
- Association of Bariatric Surgery With Long-term Remission of Type 2 Diabetes and With Microvascular and Macrovascular Complications
- (2014) Lars Sjöström et al. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
- Carriage of the PNPLA3 rs738409 C >G polymorphism confers an increased risk of non-alcoholic fatty liver disease associated hepatocellular carcinoma
- (2014) Y.-L. Liu et al. JOURNAL OF HEPATOLOGY
- The combination of liver stiffness measurement and NAFLD fibrosis score improves the noninvasive diagnostic accuracy for severe liver fibrosis in patients with nonalcoholic fatty liver disease
- (2014) Salvatore Petta et al. LIVER INTERNATIONAL
- Radiologic evaluation of nonalcoholic fatty liver disease
- (2014) Seung Soo Lee WORLD JOURNAL OF GASTROENTEROLOGY
- Vitamin E and changes in serum alanine aminotransferase levels in patients with non-alcoholic steatohepatitis
- (2013) J. H. Hoofnagle et al. ALIMENTARY PHARMACOLOGY & THERAPEUTICS
- QUADAS-2: A Revised Tool for the Quality Assessment of Diagnostic Accuracy Studies
- (2013) Penny F. Whiting ANNALS OF INTERNAL MEDICINE
- Outcomes of Liver Transplantation for Nonalcoholic Steatohepatitis: A Systematic Review and Meta-analysis
- (2013) Xiaofei Wang et al. Clinical Gastroenterology and Hepatology
- Adherence to the Mediterranean diet is associated with the severity of non-alcoholic fatty liver disease
- (2013) Meropi D. Kontogianni et al. CLINICAL NUTRITION
- Non-alcoholic fatty liver disease is associated with an increased prevalence of atrial fibrillation in hospitalized patients with Type 2 diabetes
- (2013) Giovanni Targher et al. CLINICAL SCIENCE
- Dapagliflozin maintains glycaemic control while reducing weight and body fat mass over 2 years in patients with type 2 diabetes mellitus inadequately controlled on metformin
- (2013) J. Bolinder et al. DIABETES OBESITY & METABOLISM
- Simple Noninvasive Systems Predict Long-term Outcomes of Patients With Nonalcoholic Fatty Liver Disease
- (2013) Paul Angulo et al. GASTROENTEROLOGY
- Modest alcohol consumption decreases the risk of non-alcoholic fatty liver disease: a meta-analysis of 43 175 individuals
- (2013) Silvia Sookoian et al. GUT
- The Effect of Pioglitazone and Metformin on Liver Function Tests, Insulin Resistance, and Liver Fat Content in Nonalcoholic Fatty Liver Disease: A Randomized Double Blinded Clinical Trial
- (2013) Mohsen Razavizade et al. Hepatitis Monthly
- Nonalcoholic steatohepatitis is the most rapidly growing indication for liver transplantation in patients with hepatocellular carcinoma in the U.S.
- (2013) Robert J. Wong et al. HEPATOLOGY
- Efficacy and safety of canagliflozin in patients with type 2 diabetes mellitus inadequately controlled with metformin and sulphonylurea: a randomised trial
- (2013) J. P. H. Wilding et al. INTERNATIONAL JOURNAL OF CLINICAL PRACTICE
- Resolution of Fatty Liver and Risk of Incident Diabetes
- (2013) Ki-Chul Sung et al. JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM
- The Mediterranean diet improves hepatic steatosis and insulin sensitivity in individuals with non-alcoholic fatty liver disease
- (2013) Marno C. Ryan et al. JOURNAL OF HEPATOLOGY
- From NAFLD in clinical practice to answers from guidelines
- (2013) Fabio Nascimbeni et al. JOURNAL OF HEPATOLOGY
- Community-based lifestyle modification programme for non-alcoholic fatty liver disease: A randomized controlled trial
- (2013) Vincent Wai-Sun Wong et al. JOURNAL OF HEPATOLOGY
- A population-based study on the prevalence of NASH using scores validated against liver histology
- (2013) Jenni Hyysalo et al. JOURNAL OF HEPATOLOGY
- Body mass index in childhood and adult risk of primary liver cancer
- (2013) Tina Landsvig Berentzen et al. JOURNAL OF HEPATOLOGY
- Hepatocellular cancer: The impact of obesity, type 2 diabetes and a multidisciplinary team
- (2013) Jessica Dyson et al. JOURNAL OF HEPATOLOGY
- Progression of NAFLD to diabetes mellitus, cardiovascular disease or cirrhosis
- (2013) Quentin M. Anstee et al. Nature Reviews Gastroenterology & Hepatology
- Cardiovascular Effects of Intensive Lifestyle Intervention in Type 2 Diabetes
- (2013) NEW ENGLAND JOURNAL OF MEDICINE
- Long-Term Effect of Bariatric Surgery on Liver Enzymes in the Swedish Obese Subjects (SOS) Study
- (2013) Maria Antonella Burza et al. PLoS One
- Laparoscopic sleeve gastrectomy is safe and efficacious for pretransplant candidates
- (2013) Matthew Y.C. Lin et al. Surgery for Obesity and Related Diseases
- Nonalcoholic fatty liver and metabolic syndrome in Italy: results from a multicentric study of the Italian Arteriosclerosis society
- (2012) Maurizio Soresi et al. ACTA DIABETOLOGICA
- Safety and efficacy of liraglutide in patients with type 2 diabetes and elevated liver enzymes: individual patient data meta-analysis of the LEAD program
- (2012) M. J. Armstrong et al. ALIMENTARY PHARMACOLOGY & THERAPEUTICS
- Combined Liver Transplantation and Gastric Sleeve Resection for Patients With Medically Complicated Obesity and End-Stage Liver Disease
- (2012) J. K. Heimbach et al. AMERICAN JOURNAL OF TRANSPLANTATION
- Independent Association Between Nonalcoholic Fatty Liver Disease and Cardiovascular Disease in the US Population
- (2012) Maria Stepanova et al. Clinical Gastroenterology and Hepatology
- Non-alcoholic fatty liver disease: a new and important cardiovascular risk factor?
- (2012) Lokpal S. Bhatia et al. EUROPEAN HEART JOURNAL
- Pioglitazone and vitamin E for nonalcoholic steatohepatitis: A cost utility analysis
- (2012) Suzanne E. Mahady et al. HEPATOLOGY
- The diagnosis and management of non-alcoholic fatty liver disease: Practice Guideline by the American Association for the Study of Liver Diseases, American College of Gastroenterology, and the American Gastroenterological Association
- (2012) Naga Chalasani et al. HEPATOLOGY
- Determination of reliability criteria for liver stiffness evaluation by transient elastography
- (2012) Jérôme Boursier et al. HEPATOLOGY
- Association between noninvasive fibrosis markers and mortality among adults with nonalcoholic fatty liver disease in the United States
- (2012) Donghee Kim et al. HEPATOLOGY
- Bariatric Surgery and Long-term Cardiovascular Events
- (2012) Lars Sjöström et al. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
- Effects of Dapagliflozin on Body Weight, Total Fat Mass, and Regional Adipose Tissue Distribution in Patients with Type 2 Diabetes Mellitus with Inadequate Glycemic Control on Metformin
- (2012) Jan Bolinder et al. JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM
- Metformin for Liver Cancer Prevention in Patients with Type 2 Diabetes: A Systematic Review and Meta-Analysis
- (2012) Zhi-Jiang Zhang et al. JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM
- Predictors for incidence and remission of NAFLD in the general population during a seven-year prospective follow-up
- (2012) Shira Zelber-Sagi et al. JOURNAL OF HEPATOLOGY
- Modest alcohol consumption is associated with decreased prevalence of steatohepatitis in patients with non-alcoholic fatty liver disease (NAFLD)
- (2012) Winston Dunn et al. JOURNAL OF HEPATOLOGY
- In patients with non-alcoholic fatty liver disease, metabolically abnormal individuals are at a higher risk for mortality while metabolically normal individuals are not
- (2012) Zobair M. Younossi et al. METABOLISM-CLINICAL AND EXPERIMENTAL
- Bariatric Surgery versus Conventional Medical Therapy for Type 2 Diabetes
- (2012) Geltrude Mingrone et al. NEW ENGLAND JOURNAL OF MEDICINE
- Large-Scale Long-Term Follow-Up Study of Japanese Patients With Non-Alcoholic Fatty Liver Disease for the Onset of Hepatocellular Carcinoma
- (2011) Yusuke Kawamura et al. AMERICAN JOURNAL OF GASTROENTEROLOGY
- Increased Perioperative Mortality Following Bariatric Surgery Among Patients With Cirrhosis
- (2011) Jeffrey D. Mosko et al. Clinical Gastroenterology and Hepatology
- Rosiglitazone versus rosiglitazone and metformin versus rosiglitazone and losartan in the treatment of nonalcoholic steatohepatitis in humans: A 12-month randomized, prospective, open- label trial
- (2011) Dawn M. Torres et al. HEPATOLOGY
- Diagnostic accuracy and reliability of ultrasonography for the detection of fatty liver: A meta-analysis
- (2011) Ruben Hernaez et al. HEPATOLOGY
- Effect of Vitamin E or Metformin for Treatment of Nonalcoholic Fatty Liver Disease in Children and Adolescents
- (2011) Joel E. Lavine JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
- Vitamin E and the Risk of Prostate Cancer
- (2011) Eric A. Klein et al. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
- Newly diagnosed diabetes mellitus as a risk factor for serious liver disease
- (2010) L. Porepa et al. CANADIAN MEDICAL ASSOCIATION JOURNAL
- High-dose ursodeoxycholic acid therapy for nonalcoholic steatohepatitis: a double-blind, randomized, placebo-controlled trial
- (2010) Ulrich F. H. Leuschner et al. HEPATOLOGY
- The incidence and risk factors of hepatocellular carcinoma in patients with nonalcoholic steatohepatitis
- (2010) Mustafa S. Ascha et al. HEPATOLOGY
- Performance of the aspartate aminotransferase-to-platelet ratio index for the staging of hepatitis C-related fibrosis: An updated meta-analysis
- (2010) Zhong-Hua Lin et al. HEPATOLOGY
- Fatty liver incidence and predictive variables
- (2010) Akira Tsuneto et al. HYPERTENSION RESEARCH
- GRADE guidelines: 2. Framing the question and deciding on important outcomes
- (2010) Gordon H. Guyatt et al. JOURNAL OF CLINICAL EPIDEMIOLOGY
- Risk of nonalcoholic steatohepatitis and fibrosis in patients with nonalcoholic fatty liver disease and low visceral adiposity
- (2010) Anna Ludovica Fracanzani et al. JOURNAL OF HEPATOLOGY
- A randomized controlled trial of high-dose ursodesoxycholic acid for nonalcoholic steatohepatitis
- (2010) Vlad Ratziu et al. JOURNAL OF HEPATOLOGY
- Pioglitazone, Vitamin E, or Placebo for Nonalcoholic Steatohepatitis
- (2010) Arun J. Sanyal et al. NEW ENGLAND JOURNAL OF MEDICINE
- Cognitive-Behavioral Treatment of Nonalcoholic Fatty Liver Disease: A Propensity Score-Adjusted Observational Study
- (2010) Simona Moscatiello et al. Obesity
- Harmonizing the Metabolic Syndrome
- (2009) K.G.M.M. Alberti et al. CIRCULATION
- Lifestyle Modification as the Primary Treatment of NASH
- (2009) Brent A. Neuschwander-Tetri Clinics in Liver Disease
- Efficacy of insulin-sensitizing agents in nonalcoholic fatty liver disease
- (2009) Ziya Omer et al. EUROPEAN JOURNAL OF GASTROENTEROLOGY & HEPATOLOGY
- Randomized controlled trial testing the effects of weight loss on nonalcoholic steatohepatitis
- (2009) Kittichai Promrat et al. HEPATOLOGY
- Independent effects of physical activity in patients with nonalcoholic fatty liver disease
- (2009) Alexis St. George et al. HEPATOLOGY
- Soft drink consumption is associated with fatty liver disease independent of metabolic syndrome
- (2009) Ali Abid et al. JOURNAL OF HEPATOLOGY
- Metformin in patients with non-alcoholic fatty liver disease: A randomized, controlled trial
- (2009) John Willy Haukeland et al. SCANDINAVIAN JOURNAL OF GASTROENTEROLOGY
- Rosiglitazone for Nonalcoholic Steatohepatitis: One-Year Results of the Randomized Placebo-Controlled Fatty Liver Improvement With Rosiglitazone Therapy (FLIRT) Trial
- (2008) Vlad Ratziu et al. GASTROENTEROLOGY
- Randomized, Placebo-Controlled Trial of Pioglitazone in Nondiabetic Subjects With Nonalcoholic Steatohepatitis
- (2008) Guruprasad P. Aithal et al. GASTROENTEROLOGY
- Development and validation of a simple NAFLD clinical scoring system for identifying patients without advanced disease
- (2008) S A Harrison et al. GUT
- Role of leisure-time physical activity in nonalcoholic fatty liver disease: A population-based study
- (2008) Shira Zelber-Sagi et al. HEPATOLOGY
- Laparoscopic bariatric surgery improves candidacy in morbidly obese patients awaiting transplantation
- (2008) Mark C. Takata et al. Surgery for Obesity and Related Diseases
- Microvascular Autonomic Dysfunction May Justify False-Positive Stress Myocardial Perfusion Imaging in Patients With Liver Cirrhosis Undergoing Liver Transplantation
- (2008) M. Senzolo et al. TRANSPLANTATION PROCEEDINGS
Discover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversationAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started